313 related articles for article (PubMed ID: 20838203)
21. Tuberculosis infections and tumor necrosis factor alpha antagonists.
Gan J; Manadan AM; Sequiera W; Block JA
Am J Ther; 2013 Jan; 20(1):73-8. PubMed ID: 21519217
[TBL] [Abstract][Full Text] [Related]
22. [Reactivation of tuberculosis with Mycobacterium bovis infection of the oral mucosa during immunosuppression].
Ernst D; Bange FC; Rana A; Baerlecken N; Puls F; Schmidt RE; Stoll M
Dtsch Med Wochenschr; 2010 Jun; 135(23):1179-81. PubMed ID: 20514598
[TBL] [Abstract][Full Text] [Related]
23. Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union.
Smith MY; Attig B; McNamee L; Eagle T
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1168-73. PubMed ID: 22794309
[TBL] [Abstract][Full Text] [Related]
24. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
[TBL] [Abstract][Full Text] [Related]
26. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
27. [Meningeal and Guillain-Barrè syndrome in a patient with rheumatoid arthritis receiving adalimumab therapy].
López Méndez P; Martín Santana I; del Pino Reyes Yánez M; Ruano Hernández A; Hernández Beriain JÁ; Hervás García M
Reumatol Clin; 2011; 7(6):401-3. PubMed ID: 22078700
[TBL] [Abstract][Full Text] [Related]
28. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
[TBL] [Abstract][Full Text] [Related]
29. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
30. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Keystone EC; Papp KA; Wobeser W
J Rheumatol; 2011 Jul; 38(7):1234-43. PubMed ID: 21459944
[TBL] [Abstract][Full Text] [Related]
31. Sarcoid-related uveitis occurring during adalimumab therapy.
Seve P; Varron L; Broussolle C; Denis P; Kodjikian L
Ocul Immunol Inflamm; 2012 Feb; 20(1):59-60. PubMed ID: 22017197
[TBL] [Abstract][Full Text] [Related]
32. Tubercular pyomyositis in a case of rheumatoid arthritis being treated with infliximab.
Khosla P; Aroaa N; Jain S
Int J Rheum Dis; 2010 Feb; 13(1):82-5. PubMed ID: 20374389
[TBL] [Abstract][Full Text] [Related]
33. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
[TBL] [Abstract][Full Text] [Related]
34. A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment.
Sartori NS; Picon P; Papke A; Neyeloff JL; da Silva Chakr RM
PLoS One; 2019; 14(12):e0224963. PubMed ID: 31790428
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
[TBL] [Abstract][Full Text] [Related]
36. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system manifestations of tuberculosis-associated immune reconstitution inflammatory syndrome during adalimumab therapy: a case report and review of the literature.
Tanaka T; Sekine A; Tsunoda Y; Takoi H; Lin SY; Yatagai Y; Hayasihara K; Saito T
Intern Med; 2015; 54(7):847-51. PubMed ID: 25832955
[TBL] [Abstract][Full Text] [Related]
38. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
Mohan AK; Coté TR; Block JA; Manadan AM; Siegel JN; Braun MM
Clin Infect Dis; 2004 Aug; 39(3):295-9. PubMed ID: 15306993
[TBL] [Abstract][Full Text] [Related]
40. Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
Nordgaard-Lassen I; Dahlerup JF; Belard E; Gerstoft J; Kjeldsen J; Kragballe K; Ravn P; Sørensen IJ; Theede K; Tjellesen L;
Dan Med J; 2012 Jul; 59(7):C4480. PubMed ID: 22759856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
